This FERNE Journal Club addresses the specific issue of how brain biomarker lab testing can be used to enhance the emergency care of mild traumatic brain injury (mTBI) patients.
This analysis of the optimal care of mTBI patients with possible concussion includes important clinical concepts regarding the potential use of brain biomarker labs.
The discussion of brain biomarkers for mTBI patient care includes the following:
- A description of the tested brain biomarkers
- The test characteristics, especially sensitivity and NPV
- What platforms are available for use in which settings
- How the use of brain biomarkers can safely reduce CT use
- Clinical utility and cost issues related to brain biomarkers
- Potential use as described in society generated clinical policies
24 references were used, so that clinicians can review multiple publications that address the clinical questions related to brain biomarkers use for mTBI patients.
MILD TBI PATIENT EVALUATION: BRAIN BIOMARKERS TESTING
Brain Biomarker Document Description
What this FERNE Document Provides to the Learning Clinician:
- Information for the clinician on the potential use of brain biomarker lab testing in emergency patients with minor traumatic brain injury (mTBI) and possible concussion.
- A clinical imperative and a representative patient history.
- 29 clinically relevant questions related to use of brain biomarkers for the purpose of excluding the need for CT brain non-contrast neuroimaging.
- Three bullet pointed clinical answers to the 29 clinical questions with a brief description of each answer from 24 references chosen by the editor.
- 30 statements that summarize the information from the clinical answers.
- A summary statement that clarifies the key journal club learning point.
A description of the 24 references chosen for this FERNE journal club.
A JAMA formatted reference list of the 24 sources.
A description of how AI was used in the production of this journal club and how this educational tool is intended for use.